VPN Plus+ ExclusiveWhat to look for in a quality CBD productNovember 3, 2022Imagine if the pharmaceuticals we prescribe for animals harbored unclear and undisclosed ingredients, in any quantity, with minimal evidence about their safety or effectiveness, and chemical makeup that varied with each shipment. This might sound intolerable, but it describes the status of not only cannabis, but botanical medicine in general.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
VPN Plus+ ExclusiveCBD or CBD and THC combined?May 29, 2020While cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) are both phytocannabinoids derived from cannabis plants, differences in their chemical structures allow each to interact with unique receptors, resulting in distinct molecular targets and physiological effects. Namely, THC shows high affinity toward CB1 receptors, which are present in central and peripheral neurons, resulting in the euphoric effect commonly attributed to cannabis intoxication. In contrast, CBD does not bind CB1 at relevant concentrations and is nonintoxicating. Instead, CBD interacts, to various degrees, with other receptors (agonism at TRPV1 and 5-HT1A, antagonism at TNFα, GPR55, and GPR18), which may be relevant for its suggested therapeutic effects. Practical considerations Recently, CBD- and THC-containing products for people and pets have become more widely available, especially in jurisdictions that have passed legislation allowing the sale of such items intended for human use. Evolving regulatory frameworks and social perceptions have also renewed interest in the potential therapeutic properties of cannabinoids for animals. Importantly, there are no authorized veterinary drugs containing cannabinoids in the U.S., and any state laws permitting the use of medical cannabis do not apply to use in animals. Increasingly, the veterinary profession is being asked to weigh in on the potential roles of CBD and …
CBD and hemp product claims spike by 300 percent, says TrupanionApril 11, 2019Pet insurance claims for cannabidiol (CBD) and hemp products increased by 300 percent between 2017 and 2018. This is according to Trupanion, which says it has seen a large increase in submitted claims relating to CBD products over the past six years. The insurance company found more than 20 percent of Americans were living in states where recreational marijuana use was legal by 2017. This is up from five percent before California, Massachusetts, and Nevada were added to the list of states where it's legal. Based on Trupanion's data, the U.S. states with the most claims for CBD are: 1) Washington 2) New Jersey 3) Florida 4) New York There is an abundance of anecdotal evidence supporting the benefits of CBD and hemp products to pets, but little formal research. Tetrahydrocannabinol (THC) is toxic to pets, causing balance problems, irregular heartbeat, incontinence, or worse. Inhalation by second-hand smoke can be dangerous too, as well as edible forms of THC. The top conditions pet owners use CBD or hemp for their pets are seizures, musculoskeletal issues, such as arthritis and hip dysplasia, cancer, and behavioral issues, like anxiety.
